It’s a complete merge with Generex owning and controlling the new company, NuGenerex immuno-oncology gets a great team to put around Eric and our science, we get 4 class A platform assets, with CAR T and oral delivery being high high potential winners as well as the Diamond AI technology and other red hot button winning areas.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links